Exploring the Nature, Assessment and Treatment of Stuttering
The Blank Center CARE Model™: An Anti-Ableist Approach to Treatment
University of Texas at Austin
3,000 participants
May 22, 2015
INTERVENTIONAL
Conditions
Summary
The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.
Eligibility
Inclusion Criteria9
- A participant will be considered a child who stutters (ages 2-17 years) if
- their parent/caregiver reports concern that their child is a person who stutters,
- they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
- they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4).
- A participant will be considered an adult who stutters (18+ years) if
- they report they are a person who stutters,
- they have received a formal diagnosis of stuttering from a certified speech-language pathologist,
- they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or
- they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The over-arching goal of the Blank Center CARE Model is to ensure individuals who stutter communicate effectively, advocate for themselves in a manner that maintains agency, and ensure their quality of life does not depend on producing, or attempting to control, stuttered speech.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05908123